Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$arqt](/topic/$arqt)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-10-31  
**1-Year Low**: XX% on 2025-04-01  

**Most Supportive Themes**
- **Upcoming FDA Decision:** (40%) The upcoming FDA decision on May 22nd for Arcutis Biotherapeutics' topical foam treatment is a major catalyst.
- **Positive Sentiment:** (30%) The overall sentiment towards $ARQT is positive, with a majority of mentions on X being positive or neutral.
- **Analyst Recommendations:** (20%) Several posts highlight $ARQT as a stock to buy with significant upside potential.
  
**Most Critical Themes**
- **Market Volatility:** (10%)  General market discussions and mentions of other stocks could dilute focus on $ARQT.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %    | Negative | %  |
| ------- | -------- | -  | ------- | -    | -------- | -  |
| X       | XX       | X% | XXXXX   | XXX% | X        | X% |
|         |          |    |         |      |          |    |
| Total   | XX       | X% | XXXXX   | XXX% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$arqt

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-31
1-Year Low: XX% on 2025-04-01

Most Supportive Themes

  • Upcoming FDA Decision: (40%) The upcoming FDA decision on May 22nd for Arcutis Biotherapeutics' topical foam treatment is a major catalyst.
  • Positive Sentiment: (30%) The overall sentiment towards $ARQT is positive, with a majority of mentions on X being positive or neutral.
  • Analyst Recommendations: (20%) Several posts highlight $ARQT as a stock to buy with significant upside potential.

Most Critical Themes

  • Market Volatility: (10%) General market discussions and mentions of other stocks could dilute focus on $ARQT.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX X% XXXXX XXX% X X%
Total XX X% XXXXX XXX% X X%
$arqt Sentiment
/topic/$arqt/sentiment